Streetbeat News

Stock Prices

DLNG

Dynagas LNG Partners (NYSE:DLNG) is scheduled to release its quarterly earnings report on March 27, 2024. Analysts predict an EPS of $0.30. The company's past earnings performance shows a mix of misses and beats, with the share price reacting variably. Shares are currently trading at $2.8, down 2.86% over the last year. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 4:01 pm

DRRX

Durect Corporation (NASDAQ:DRRX) is scheduled to release its quarterly earnings report on March 27, 2024, with analysts expecting an EPS of $-0.33. The company's past performance shows a pattern of beating EPS estimates, which has occasionally led to positive stock price movements the following day. However, Durect's stock has declined by 70.14% over the last year, indicating a bearish outlook among long-term shareholders. Investors will be keenly watching for not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 4:01 pm

PDSB

PDS Biotechnology (NASDAQ:PDSB) is scheduled to release its quarterly earnings report on March 27, 2024, with analysts expecting an EPS of $-0.44. The company's past earnings performance shows a mix of beats and misses, with the share price reacting accordingly. Shares are currently trading at $4.73, down 18.75% over the last year. Investors will be keenly watching for not just the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 4:01 pm

BCDA

BioCardia (NASDAQ:BCDA) is scheduled to release its quarterly earnings report on March 27, 2024, with an estimated EPS of $-0.11. Investors are looking for an earnings beat and positive guidance for the next quarter. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's miss leading to a 5.75% drop. Currently, BioCardia's shares are trading at $0.405, marking an 80.07% decline over the last 52 weeks, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 4:01 pm

SYRS

Syros Pharmaceuticals (NASDAQ:SYRS) is scheduled to release its quarterly earnings report on March 27, 2024, with analysts expecting an EPS of $-1.14. Despite missing EPS estimates last quarter, SYRS's stock price increased by 11.76% the following day. Historically, the company's actual EPS has varied from estimates, leading to mixed stock price reactions. Shares are currently trading at $6.4, reflecting a 127.6% increase over the last 52 weeks, indicating a positive outlook from long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 4:01 pm

SSIC

Silver Spike Investment (NASDAQ:SSIC) is scheduled to release its quarterly earnings report on March 27, 2024, with an estimated EPS of $0.27. Historically, the company has had mixed reactions to its earnings reports, with share price movements varying post-announcement. Over the last year, SSIC shares have increased by 16.18%, indicating a generally positive outlook from long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 4:01 pm

UGRO

Urban-gro (NASDAQ:UGRO) is scheduled to release its quarterly earnings report on March 27, 2024, with analysts expecting an EPS of $-0.13. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter resulting in a 3.08% increase following an EPS beat. Urban-gro's stock has declined by 20.36% over the last 52 weeks, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 4:01 pm

USIO

Usio (NASDAQ:USIO) is scheduled to release its quarterly earnings report on March 27, 2024, with analysts expecting an EPS of $0.00. The company's past earnings performance shows a mix of misses and beats, with the stock price reacting accordingly. Shares are currently trading at $1.61, reflecting a 9.09% increase over the last 52 weeks. Investors are looking forward to not just the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 4:01 pm

SOFI

Eight analysts have recently shared their views on SoFi Technologies (NASDAQ:SOFI), with opinions ranging from bullish to bearish. The 12-month price targets show an average of $8.38, down from $10.00, with a high of $12.00 and a low of $3.00. Analyst actions include both downgrades and maintenance of ratings, reflecting changing market dynamics and company performance. SoFi, a financial-services company, has shown notable revenue growth and a strong net margin but faces challenges in ROE and ROA. Its market capitalization is below the industry average, and it has a healthy debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 4:01 pm

SLE

Super League Enterprise (NASDAQ:SLE) is scheduled to release its quarterly earnings report on March 27, 2024, with an expected EPS of $-1.20. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historical data shows a mixed reaction to past earnings, with share prices fluctuating based on performance and guidance. Currently, SLE's shares are trading at $2.345, marking an 81.31% decline over the last year, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 4:01 pm